Are there any good reading materials on Tech M&A and valuation, especially in cases where both buyer and target is EBITDA negative and/or differ in size dramatically - so more economies of scope based acquisitions. DCFs would be less relevant here esp. if EBITDA negative persists for a bit. Would primary methodology be comps then in this case - and acc/dil would also not be relevant here
| +196 | Why UBS Is the Worst Place to Start Your IB Career | 32 | 9h |
| +159 | ONLY THESE BANKS OR YOU STRUCK OUT | 39 | 16h |
| +65 | Firm Thinks I'm Lying About Offer | 20 | 15h |
| +58 | Indiana University Fraternity Pipelines | 35 | 7h |
| +40 | Rogo AI | 20 | 3h |
| +39 | Stay at Weak Dealflow Team or Lateral? | 12 | 1d |
| +38 | Elite Boutique interview questions | 10 | 4h |
| +36 | Suspended for a Year | 19 | 26m |
| +23 | 1st Half 2026 (1H26) RX IB & RX Co. Rankings | 16 | 2h |
| +22 | Is there anything worse than having no work? | 8 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Not a tech expert by any means but will take a stab.
Most growth companies would be valued on revenue as capital is allocated to growth drivers like sales & marketing, R&D and such. So comps/precedents on revenue multiples are the way to go.
Just slap a sales or GP multiple on it and call it a day. If you want to go more in depth do rule of 40 with gross margin + rev CAGR instead of EBITDA margin + rev CAGR.Source: tech banker
Et eos ea non ab. Velit et reprehenderit repellendus eos corporis. Exercitationem occaecati vel sit veniam eligendi. Sequi provident maxime ad animi. Et id modi deserunt perspiciatis. Excepturi soluta a atque et consequatur magnam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...